NasdaqGS:SGRY
NasdaqGS:SGRYHealthcare

Is Surgery Partners Mispriced After 42.3% Five Year Slide and Outpatient Expansion?

If you are wondering whether Surgery Partners is a quietly mispriced opportunity or a value trap in the making, you are not alone. That is exactly what we are going to unpack here. The stock is down 4.9% over the last week and 22.4% year to date, but a 5.0% gain over the past month hints that sentiment may be starting to shift after a long 5 year slide of 42.3%. Recent headlines have focused on Surgery Partners expanding its network of ambulatory surgery centers and deepening relationships...
NYSE:DE
NYSE:DEMachinery

Trump’s Farm Policy Pressure and Board Shake‑Up Could Be A Game Changer For Deere (DE)

Earlier this month, Deere & Company expanded its Board from 10 to 11 directors by appointing Cargill Chair and CEO Brian Sikes as an independent director and committee member, while also announcing the upcoming retirement of President, John Deere Financial and CIO Raj Kalathur in January 2026 and affirming a quarterly dividend of US$1.62 per share payable in February 2026. At the same time, President Donald Trump’s public pressure on farm‑equipment pricing and plans to ease environmental...
NYSE:U
NYSE:USoftware

Is Unity Stock Still Attractive After Its 2025 Rally and Cash Flow Outlook?

If you are wondering whether Unity Software is still a bargain after its big rebound, or if the easy money has already been made, this breakdown will help you think through whether the current price really makes sense. The stock has climbed 9.8% over the last week, 13.6% over the past month, and is now up 99.8% year to date. However, the 5 year return of -66.6% is a reminder of how quickly market sentiment around Unity can swing. Recent price action has come alongside ongoing investor...
NYSE:GLOB
NYSE:GLOBIT

Has Globant’s 2025 AI and Cloud Expansion Created a New Value Opportunity?

Wondering if Globant is a beaten down tech name or a quiet value opportunity waiting to be rediscovered? This breakdown will help you decide whether the current price really makes sense. Despite a modest 7.9% rise over the last month, the stock is still down 67.7% year to date and 68.7% over the past year, which indicates that sentiment has been heavily reset even as some investors are starting to edge back in. Recent news has focused on Globant doubling down on digital transformation, AI...
NYSE:HLIO
NYSE:HLIOMachinery

Does Helios Technologies’ (HLIO) New Electronics President Reveal a Shift in Its Growth Priorities?

Helios Technologies has announced that Billy Aldridge will become President of its Electronics Segment on January 4, 2026, after serving as Senior Vice President, Managing Director of the segment since March 31, 2025, and building a career across Enovation Controls, FW Murphy, and Brunswick’s MerCruiser/Mercury division. This appointment elevates a leader with deep electronics and OEM experience at a time when Helios is emphasizing customer engagement and growth in its Electronics...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Efficient Sickle Cell Base-Editing Data Might Change The Case For Investing In Beam Therapeutics (BEAM)

Beam Therapeutics has released updated Phase 1/2 BEACON trial data for its investigational sickle cell therapy risto-cel, showing efficient cell collection, high base-editing levels, and sustained increases in protective hemoglobin F alongside reductions in harmful hemoglobin S in patients with severe vaso-occlusive crises. A key insight is that risto-cel’s manufacturing process appears both efficient and predictable, with most patients needing only a single stem cell collection cycle, which...
NYSE:APH
NYSE:APHElectronic

Has Amphenol’s 101% Surge in 2025 Pushed Its Valuation Too Far?

If you are wondering whether Amphenol is still a smart buy after its huge run, or if you are late to the party, this breakdown will help you assess whether the current price makes sense. The stock has paused recently, remaining flat over the last week and down about 3.6% over the past month. That follows a climb of roughly 101% year to date and 90.1% over the last year. These gains have been supported by steady demand for Amphenol's connectivity and sensor solutions across data centers,...
NYSE:CNH
NYSE:CNHMachinery

Is CNH Industrial a Value Opportunity After its 2025 Share Price Slump?

If you are wondering whether CNH Industrial is quietly turning into a value opportunity, or if the lower share price is a warning sign, this article will walk you through what the numbers are really saying. The stock has bounced 3.4% over the last week and 2.0% over the past month, but it is still down 11.5% year to date and 16.8% over the last year, which is exactly the kind of setup value investors like to investigate. Recently, the market has been reacting to shifting expectations around...
NYSE:MOS
NYSE:MOSChemicals

Has the Market Mispriced Mosaic After Recent Fertilizer Demand and Commodity Volatility?

If you have been wondering whether Mosaic is quietly turning into a value play, you are not alone. This article is going to unpack exactly what the market might be missing. The stock is down about 1.5% over the last week, 7.6% over the last month and 8.1% over the past year. It is still up 14.2% over five years, a mixed picture that can hide some interesting value dynamics. Recently, investors have been digesting headlines around fertilizer demand, shifting crop prices and the broader...
NYSE:PSA
NYSE:PSASpecialized REITs

How PSA’s Rent Softness and Aggressive Facility Acquisitions Will Impact Public Storage (PSA) Investors

Public Storage recently reported an operating update showing that average annual contract rent per square foot for new tenants declined through November 2025, even as it moved to acquire or contract to acquire 88 self-storage facilities for US$949.4 million, adding 6.1 million net rentable square feet this year. The company’s latest investor presentation underlines how this expansion of 2,565 stabilized Same Store Facilities and newly acquired properties could influence future revenue...
NYSE:TOL
NYSE:TOLConsumer Durables

What Toll Brothers (TOL)'s Soft Q4 Earnings and Lower 2026 Guidance Mean For Shareholders

Toll Brothers recently reported mixed fourth-quarter 2025 results, with revenue rising to US$3,423.4 million while net income slipped to US$446.72 million and earnings per share came in below analyst expectations amid a softer demand backdrop and a 15% decline in backlog. At the same time, the builder is pressing ahead with new luxury communities such as Wilder Ranch in Colorado, Rivercrest in Nevada, and expanded offerings in Washington, underscoring its focus on affluent buyers even as it...
NYSE:WMS
NYSE:WMSBuilding

Advanced Drainage Systems (WMS): Reassessing Valuation After Guidance Reaffirmation and Earnings Beat

Advanced Drainage Systems (WMS) is back on investors radar after a recent fund commentary highlighted its better than expected sales and earnings, as well as a reaffirmed fiscal 2026 outlook despite choppy construction markets. See our latest analysis for Advanced Drainage Systems. The latest fund commentary seems to have reminded the market what is working under the hood, with the share price now at $149.6 and a strong year to date share price return of 30.85 percent feeding into a solid 5...
NYSE:CIVI
NYSE:CIVIOil and Gas

Is Civitas Resources a 2025 Bargain After a 36% Slide and Strong Cash Flow Outlook?

Wondering whether Civitas Resources is a value play or a value trap at today’s price? You are not alone. This stock has quietly shifted from market favorite to contrarian idea. The share price has bounced about 10.5% over the last month but is still down roughly 36.4% year to date and 33.8% over the last year, a mix that often signals either a looming problem or a mispriced opportunity. Recent headlines around Civitas have focused on its portfolio positioning and capital discipline in a...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

How Attractive Is Ultragenyx Pharmaceutical After Recent Rare Disease Pipeline Progress?

If you are wondering whether Ultragenyx Pharmaceutical at around $36 a share is a hidden bargain or another biotech value trap, you are in the right place to unpack what the market is really pricing in. The stock is up about 8.3% over the last month but still down sharply over 1 year and 5 years. This pattern suggests sentiment may be shifting even while longer term holders are still deep in the red. Recent attention on Ultragenyx has centered on its rare disease pipeline progress and...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Critical Metals (CRML): Valuation Check After Transformative EU Rare Earth JV with Romanian State-Owned Partner

Critical Metals (CRML) just took a big strategic step, executing a 50/50 joint venture term sheet with Romanian state-owned FPCU to build a rare earth processing facility in the European Union without adding debt or equity dilution. See our latest analysis for Critical Metals. The JV news lands after a volatile run, with the 90 day share price return of 44.9 percent and year to date share price return of 37.9 percent contrasting with a softer 22.2 percent one year total shareholder return...
NYSE:BLD
NYSE:BLDConsumer Durables

Fed Rate Cut and Q3 Beat Could Be A Game Changer For TopBuild (BLD)

In recent days, TopBuild Corp. reported a third quarter revenue increase of 1.4% year over year, modestly above analyst expectations, alongside commentary highlighting productivity gains and continued strength in profitability across its Installation Services and Specialty Distribution segments. At the same time, the Federal Reserve’s interest rate cut has improved sentiment toward housing-related companies like TopBuild, intersecting with management’s renewed focus on growth strategies...
NasdaqGS:MGPI
NasdaqGS:MGPIBeverage

MGP Ingredients (MGPI): Reassessing Valuation After Chairman’s Share Sale and Ongoing Margin Pressures

After the Chairman of the Board moved to sell a sizable block of shares, MGP Ingredients (MGPI) quickly drew fresh scrutiny as investors weighed this signal against already weakening sales and margin pressure. See our latest analysis for MGP Ingredients. The share sale comes after a rough stretch, with the share price down sharply on a year to date basis and multi year total shareholder returns deeply negative. However, this week’s double digit 7 day share price return hints at traders...
NasdaqGS:JJSF
NasdaqGS:JJSFFood

J&J Snack Foods (JJSF): Reassessing Valuation After a Recent Share Price Bounce

J&J Snack Foods (JJSF) has quietly bounced about 13% over the past month, even as its longer term returns and revenue trend remain weak. That kind of divergence usually makes investors ask what the market is starting to price in. See our latest analysis for J&J Snack Foods. That recent 12.6% 1 month share price return looks more like a short term reset than a full trend change, given the roughly 40% year to date share price decline and weak multi year total shareholder returns. If that...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

Array Technologies (ARRY): Assessing Valuation After Two Years of Declining Sales and Earnings

Array Technologies (ARRY) is back in focus after fresh analysis underscored two tough years of roughly 10% annual declines in both sales and earnings per share, along with weakening returns on capital. See our latest analysis for Array Technologies. Even with those operational headwinds, the stock has shown some renewed interest, with a 1 day share price return of 7.69 percent and a year to date share price gain of 30.86 percent. However, the 3 year total shareholder return of negative 62.55...
NYSE:KRG
NYSE:KRGRetail REITs

Kite Realty Group Trust (KRG): Reassessing Valuation After Major Asset Sales and Capital Reallocation Strategy

Kite Realty Group Trust (KRG) just wrapped up roughly $474 million of property sales, mainly large format retail centers, and is recycling that cash into new assets, buybacks, debt reduction, and possibly a special dividend. See our latest analysis for Kite Realty Group Trust. Despite that decisive reshaping of the portfolio, Kite Realty Group Trust’s share price has drifted lower year to date, with a negative 1 year total shareholder return. However, a strong 5 year total shareholder return...
NYSE:DDD
NYSE:DDDMachinery

3D Systems (DDD): Reassessing Valuation After Convertible Debt-for-Equity Swap and Capital Structure Shake-Up

3D Systems (DDD) just shook up its balance sheet, agreeing to swap about $30.8 million of its 2026 convertible notes for roughly 16.6 million new shares, a debt reducing move that immediately hit the stock. See our latest analysis for 3D Systems. The sharp reaction to this debt for equity swap fits into a tougher stretch for 3D Systems, with a steep 7 day share price return of minus 19.9 percent and a 1 year total shareholder return of minus 47.5 percent, suggesting fading momentum as...
NYSE:AVB
NYSE:AVBResidential REITs

AvalonBay Communities (AVB): Revisiting Valuation After Asset Sales Plan and Aggressive 2025 Buybacks

AvalonBay Communities (AVB) is back in the spotlight after revealing at Nareit’s REITworld Conference that it plans to sell three apartment communities and has been aggressively buying back its own stock in 2025. See our latest analysis for AvalonBay Communities. Those planned asset sales and hefty buybacks come after a tough stretch, with the share price down sharply on a year to date basis while the five year total shareholder return remains solidly positive. This suggests that long term...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Does Roper Technologies’ 2025 Slide Create a Long Term Opportunity for Investors?

Wondering if Roper Technologies is quietly turning into a value opportunity while everyone is distracted by flashier tech names? You are not alone, and that is exactly what we are going to unpack here. Despite being a high quality software and technology conglomerate, the stock has slipped, down about 0.8% over the last week, 1.7% over the last month, and 13.9% year to date, leaving it roughly 19.1% lower than a year ago even though 5 year returns are still positive at 8.1%. Recent moves...
NYSE:PHR
NYSE:PHRHealthcare Services

Phreesia (PHR) Turns Q2 Profit, Testing Long‑Running Bearish Profitability Narrative

Phreesia (PHR) just posted its latest quarterly scorecard with Q2 2026 revenue of about $117 million and basic EPS of $0.01, setting a clearer snapshot of where the business stands on its path toward profitability. The company has seen revenue move from roughly $102 million in Q2 2025 to $117 million in Q2 2026, while quarterly EPS has shifted from a loss of about $0.31 to a modest profit, giving investors fresh data on how quickly margins might be stabilizing from here. See our full analysis...